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Gene targeting in mice mainly employs homologous recombination (HR) in embryonic stem (ES)
cells. Although it is a standard way for production of genetically modiﬁed mice, the procedure is
laborious and time-consuming. This study describes targeting of the mouse Rosa26 locus by tran-
scription activator-like effector nucleases (TALENs). We employed TALEN-assisted HR in zygotes to
introduce constructs encoding TurboRFP and TagBFP ﬂuorescent proteins into the ﬁrst intron of
the Rosa26 gene, and in this way generated two transgenic mice. We also demonstrated that these
Rosa26-speciﬁc TALENs exhibit high targeting efﬁciency superior to that of zinc-ﬁnger nucleases
(ZFNs) speciﬁc for the same targeting sequence. Moreover, we devised a reporter assay to assess
TALENs activity and speciﬁcity to improve the quality of TALEN-assisted targeting.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical
Societies. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/3.0/).1. Introduction
Genetically modiﬁed mouse models are indispensable tools to
reveal principal mechanisms of gene functions. Homologous
recombination (HR) in ES cells is routinely used to manipulate
genes in mice [1]. However, establishment of an ES cells line with
a disrupted or modiﬁed ‘‘gene of interest’’ includes several tasks
that involve introduction of the targeting construct into ES cells,
identiﬁcation of desired cell clones and their injection into blasto-
cysts, and chimeric mice breeding. Since some of these tasks are
often inefﬁcient, the generation of genetically modiﬁed mice can
represent a rather tedious and expensive procedure [2].
Recent progress in targeting strategies based on programmable
nucleases that include zinc-ﬁnger nucleases (ZFNs), transcriptionactivator-like effector nuclease (TALENs), and clustered regularly
interspaced short palindromic repeats (CRISPR)/Cas RNA-guided
nucleases opened new possibilities for fast and efﬁcient generation
of mutant animals when compared to the ‘‘conventional’’ method-
ology employing ES cells [1]. The site-speciﬁc nucleases can be
designed to cleave genomic DNA at a preselected site, which signif-
icantly increases the frequency of HR events in the targeted locus
[3]. Importantly, programmable nucleases can facilitate targeted
mutagenesis in zygotes where the frequency of HR between exog-
enous DNA and intact chromosomal loci is too low to be employed
for efﬁcient gene modiﬁcation without these new molecular tools.
It was shown previously that zygotic co-injection of ZFN mRNA
with a DNA template that includes sequences homologous to geno-
mic DNA ﬂanking the cleavage site leads to efﬁcient insertion of
the DNA template into the target site [4,5]. However, usage of ZFNs
might be associated with certain disadvantages. The DNA-binding
domain (DBD) of ZFN consists of three or four protein modules,
each recognizing three base pairs. Thus, several of 64 unique mod-
ules are required to design ZFN speciﬁc to a genomic target
sequence. This makes the assembly of the desired zinc-ﬁnger com-
binations rather a complicated process. It has also been shown that
the speciﬁcity of the individual zinc-ﬁnger domain is inﬂuenced by
the neighboring domains and by the context of the DNA target
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[6,7]. Although new tools for selection and assembly of ZFNs have
been developed recently [7,8], it is becoming evident that TALENs
and CRISPR/Cas9 systems will prevail over ZFN in future
applications.
The TALEN-DBD consists of multiple 33–35 amino-acid repeats
followed by the terminal repeat composed of 20 amino acids. Each
repeat recognizes one base pair [9] and the combination of various
repeats determines the speciﬁcity of individual TALENs for a cer-
tain DNA motif. This allows simple and effective assembly of
TALENs [10]. TALENs can be assembled using several methods
including the fast ligation-based automatable solid-phase high-
throughput (FLASH) system [11], and the Golden Gate cloning sys-
tem that has become broadly used [10,12,13].
Since efﬁcient targeting of the Rosa26 locus is of general impor-
tance to introduce single-copy transgenes, we generated TALENs
that are effective in HR-based gene targeting in mouse zygotes
using long double-stranded DNA as a template. We used two con-
structs encoding red and blue ﬂuorescent proteins to prove that
these designed Rosa26-speciﬁc TALENs are effective in assisted
HR in zygotes [4,5]. Furthermore, the efﬁciency of TALEN-based
modiﬁcation of the Rosa26 locus was compared to commercially
available ZFNs targeting the same sequence.
2. Materials and methods
2.1. Rosa26-speciﬁc TALENs and ZFNs, in vitro transcription and mRNA
polyadenylation
TALENs were designed using TAL Effector Nucleotide Targeter
2.0 (https://tale-nt.cac.cornell.edu/) [10,14], assembled using the
Golden Gate Cloning system [10], and cloned into the ELD-KKR
backbone plasmid as described previously [15]. TALEN recognizing
Rosa26 50 site contained the following repeats: HD-NN-NG-NN-NI-
NG-HD-NG-NN-HD-NI-NI-HD-NG-HD-HD-NI-NN-NG. TALEN rec-
ognizing the Rosa26 30 site contained the following repeats:
NN-HD-HD-HD-NI-NN-NI-NI-NN-NI-HD-NG-HD-HD-HD-NN-HD
(Fig. 1A). Each plasmid was linearized with NotI and transcribed
using mMESSAGE mMACHINE T7 Kit (Ambion). Polyadenylation
of resulting mRNAs was performed using Poly(A) Tailing Kit (Ambi-
on); mRNA was puriﬁed with RNeasy Mini columns (Qiagen).
TALEN mRNAs diluted in water were kept at 80 C. Both plasmids
encoding TALENs speciﬁc for Rosa26 locus are available for scien-
tiﬁc community as Addgene plasmids 60025 and 60026. ZFN
mRNAs targeting the Rosa26 locus were obtained from CompoZr
Targeted Integration Kit – mRosa26 (Sigma).
2.2. Generation of the pZDonor-Blueﬂirt targeting construct
A neomycin resistance gene driven by the phosphoglycerate
kinase (pGK) promoter (NeoR) followed by two successive Herpes
simplex virus thymidine kinase (HSV TK) and Simian virus early
(SV40E) polyA signals (pAs; both pAs were ampliﬁed from the
pEGFP-C1 vector; Clontech) were placed downstream of the
strong ubiquitous chicken b-actin promoter/rabbit b-globin splice
acceptor combined with cytomegalovirus (CMV) enhancer
(CAGEN; kindly provided by C. Cepko via Addgene). The assem-
bled NeoRpApA cassette was ﬂanked by a pair of consensus Flp
recognition target sites (FRT) derived from the pEasyFlirt targeting
vector [27]. Complementary DNA encoding TagBFP ﬂuorescent
protein was purchased from Evrogen. The 800 bp long Rosa26
homology arms were obtained from pZDonor-mRosa26 plasmid
(Sigma). A publicly available variant of the plasmid designed for
the same site of Rosa26 is available as the Addgene plasmid
37200 [17].2.3. Generation of pZDonor-TurboRFP targeting construct and pAR-
TurboRFP reporter
Complementary DNA encoding TurboRFP (ampliﬁed from
pTripz vector; Open Biosystems), terminated by the SV40E pA,
was placed downstream of the CAGEN enhancer/promoter ele-
ment. The TurboRFP expression cassette was ﬂanked by the Rosa26
homology arms as described for the pZDonor-Blueﬂirt targeting
construct. To create the pAR-TurboRFP reporter, fragments
encoding nucleotides (nt) 1–230 and 4–696 of the TurboRFP gene,
separated by a linker containing the EcoRV restriction endonucle-
ase site, were cloned into MCS2 of the pVITRO2 dual-expression
plasmid (Invivogen) downstream of a human ferritin heavy chain
composite promoter (hFerH). In addition, the enhanced green
ﬂuorescent protein (EGFP) coding sequence was ampliﬁed from
pEGFP-C1 plasmid (Clontech) and subcloned into MCS1 of pVITRO2
downstream of a human ferritin light chain composite promoter
(hFerL). TALEN target and putative off-target sequences were
inserted into the resulting pAR-TurboRFP plasmid using EcoRV.
pAR-TurboRFP reporter is available for scientiﬁc community as
Addgene plasmid 60021.
2.4. Analysis of targeting
To isolate the genomic DNA from developing embryos (3.5 days
after injection), cells were transferred into 10 ll of 1 DreamTaq
Green buffer (Thermo Scientiﬁc) supplemented with 0.4% (v/v)
NP-40 (Fluka), 0.4% (v/v) Tween-20 (Fluka), and proteinase K
(0.4 mg/ml; Thermo Scientiﬁc) and incubated for 30 min at 60 C
and 5 min at 95 C. 3 ll of the reaction were used as a template
for PCR reaction. PCR for the restriction fragment length polymor-
phism (RFLP) analysis was performed using primers F1 and R1
(Table S1). Puriﬁed PCR products were digested with XbaI (Thermo
Scientiﬁc).
2.5. T7 endonuclease sensitivity assay
Mouse genomic DNA was extracted from tail biopsies to amplify
the Rosa26 target site (primers F1 and R1) and predicted off-target
sites (primers OTch11 F and OTch11 R, OTch12 F and OTch12 R, OTch16 F
and OTch16 R). PCR products of founder mice were combined with
those obtained from wild-type (wt) mice, denatured, re-annealed,
and puriﬁed by PCR puriﬁcation kit (Thermo Scientiﬁc). Puriﬁed
fragments were treated with T7 endonuclease (New England Bio-
labs) at 37 C for 4 h.
Additional Materials and Methods are provided in Supplemen-
tary Material.
3. Results
3.1. Efﬁcient targeting of the mouse Rosa26 locus by TALENs
The Rosa26 locus is frequently targeted in ES cells to obtain
ubiquitous or controlled expression of various genes in the mouse
[4,5,16]. To acquire an easy and efﬁcient way to introduce single-
copy constructs into the Rosa26 locus, we designed and generated
a TALEN pair (designated TALENRosa26) speciﬁc for a sequence in
the Rosa26 ﬁrst intron. TALENs were designed to be separated by
a 15-bp spacer to speciﬁcally target a site overlapping with the
XbaI restriction endonuclease recognition sequence (Fig. 1A). To
test TALENRosa26-mediated modiﬁcation of the Rosa26 locus,
in vitro transcribed TALENRosa26 mRNAs were injected into the
cytoplasm of fertilized mouse oocytes. To compare the TALEN efﬁ-
ciency, ZFN [17] mRNAs encoding the Rosa26-speciﬁc ZFN pair
(ZFNRosa26) were injected in parallel. We observed that 30% of
ZFNRosa26 TALENRosa26
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Fig. 1. Design of TALENRosa26 and comparison of its activity to ZFNRosa26 in early embryos. (A) Position of the TALEN (blue underline) and ZFN (red underline) binding sites in
the Rosa26 locus. XbaI restriction site sequence used for RFLP analysis is indicated by black line above the sequence. F1 and R1 indicate positions of primers used for PCR. (B)
Embryos expressing TALENRosa26 display increased viability in comparison to embryos producing ZFNRosa26. Fertilized oocytes were injected with the indicated concentrations
of mRNA (total concentration of mRNA is given) and scored at the 8-cell stage. (C) RFLP analysis of PCR fragments ampliﬁed from genomic DNA isolated from 8-cell stage
embryos using F1 and R1 primers. Mouse zygotes were injected with ZFNRosa26 (samples #1–#10) or TALENRosa26 (#11–#20) mRNAs at 20 ng/ll concentration and harvested
72 h later. PCR products (upper images) were digested using XbaI enzyme (bottom images). Presence of the 445 bp fragment after XbaI digestion marks the TALEN-mutated
allele, whereas XbaI cleavage products (214 and 231 bp fragments) correspond to the wt allele. (D) Diagram summarizing results of the RFLP analysis (numeric values are
given in Table 1); NHEJ, non-homologous end joining.
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20 ng/ll (total mRNA concentration) developed to 8-cell or more
advanced stages, whereas the same level of development was
observed in only 9% of oocytes injected with ZFNRosa26 mRNA at
the same concentration. To reduce possible toxic effects, the TALEN
and ZFN mRNAs were also injected at 10 and 5 ng/ll, respectively
(total concentration; Table 1 and Fig. 1B). This lower concentration
of ZFNRosa26 mRNAs increased the embryo survival to 23%. In con-
trast, the embryo viability at the lower dosage of TALENRosa26
mRNAs (10 ng/ll) was virtually the same as observed at higher
mRNA concentration.To further assess the activity of the injected nucleases, RFLP
analysis of 445-bp DNA fragments ampliﬁed from genomic DNA
isolated from in vitro developing embryos was performed. While
full cleavage of the PCR product by XbaI nuclease was observed
with control embryos (Fig. 1C), some of the PCR fragments ampli-
ﬁed from DNA isolated from TALEN- or ZFN-injected embryos
showed impaired XbaI cleavage. The RFLP analysis revealed that
81% of embryos carried mono- or bi-allelic loss of the XbaI site at
20 ng/ll TALEN mRNA concentration. Dilution of TALEN mRNAs
to 10 ng/ll reduced the efﬁciency to 74%. ZFNs displayed a consid-
erably lower mutagenic effect with 18% and 21%mutation-carrying
Table 1
Summary of TALENRosa26 and ZFNRosa26 microinjection experiments.
mRNA (ng/ll) Construct Injected zygotes Developed embryos Zygotes implanted Mice born NHEJ mono-allelic NHEJ bi-allelic HR
Embryos
ZFN 20 – 120 11 – – 2 0 N/A
ZFN 5 – 120 28 – – 6 0 N/A
TALEN 20 – 120 36 – – 8 21 N/A
TALEN 10 – 120 38 – – 12 16 N/A
TALEN 20 pZDonor-Blueﬂirt circular 5 ng/ll 120 32 – – N/A N/A 1
TALEN 20 Blueﬂirt fragment 5 ng/ll 120 30 – – N/A N/A 3
Mice
TALEN 20 Blueﬂirt fragment 5 ng/ll 400 – 374 17 4 9 1
TALEN 20 TurboRFP fragment 5 ng/ll 426 – 398 17 1 8 3
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(Fig. 1D and Table 1).
3.2. TALEN-based generation of transgenic mice carrying DNA inserts
in the Rosa26 locus
To assess the efﬁcacy of TALENRosa26-assisted insertion of
exogenous DNA into the Rosa26 locus in vivo, we generated two
reporter constructs based on the pZDonor vector. The ﬁrst
construct was intended for fast monitoring of successful accom-
plishment of the targeting procedure and employed strong consti-
tutive expression of red ﬂuorescent protein TurboRFP. The second
construct, designated pZDonor-Blueﬂirt, encoded a conditional
expression cassette producing blue ﬂuorescent protein TagBFP
upon ﬂippase (Flp)-mediated recombination (Fig. 2A). The pur-
pose of this second construct was to avoid potential adverse
effects of ﬂuorescent protein overexpression and to show func-
tionality of the conditional expression, as the employed construct
included the NeoR selection cassette ﬂanked by Flp (FRT) sites
(Fig. 2A).
At ﬁrst, we compared the frequency of HR when a complete cir-
cular construct pZDonor-Blueﬂirt (total vector size 13.7 kb) or a
5.4 kb DNA fragment including the Blueﬂirt cassette ﬂanked by
800 bp Rosa26 homology arms (named Blueﬂirt targeting frag-
ment) were used. The circular construct or the DNA fragment (both
at 5 ng/ll concentration) were co-injected with TALENRosa26
mRNAs (20 ng/ll of total mRNA) into fertilized eggs and genomic
DNA isolated from 8-cell stage embryos was genotyped by PCR.
PCR analysis was performed using F5 primer derived from the
targeting vector and R4 primer annealing to the Rosa26 locus
sequence downstream of the 30 homology arm. Thus, only genomic
DNA with correct integration of the targeting vector generated the
desired PCR product. Whereas only one of 38 embryos injected
with the circular construct contained the Blueﬂirt allele, injection
of the linear DNA fragment resulted in three correctly targeted
events out of 30 embryos analyzed (Table 1). To assess the efﬁ-
ciency of targeting using linearized fragments in vivo, zygotes
microinjected with TALENRosa26 mRNAs together with either Tur-
boRFP or Blueﬂirt constructs were transferred into foster mothers
to generate Rosa26-TurboRFP and Rosa26-Blueﬂirt strains, respec-
tively. For each strain, 17 putative founder animals were born and
RFLP analysis showed that 22 out of the total 34 animals carried a
mono- or bi-allelic mutation in the Rosa26 locus (Fig. 2B). PCR and
sequencing analyses revealed correct integration of the targeting
construct in one male founder (B4) of Rosa26-Blueﬂirt strain and
in two founders (R6 and R15) of the Rosa26-TurboRFP strain. Fur-
thermore, we identiﬁed partial integration of the TurboRFP target-
ing fragment in the R8 founder (Fig. 2C). R6 and R15 mice exhibited
strong ubiquitous expression of TurboRFP protein, which was
manifested by red color of the skin. The expression of TurboRFP
was also conﬁrmed by analyses of tail tips using ﬂuorescencemicroscopy (Fig. 3A). Furthermore, male founder B4 was crossed
with C57Bl/6N females to examine the germ line transmission
and gain of function in vivo upon knock-in via recombination.
Germ line transmission was conﬁrmed using PCR analysis of F1
generation (F1) pups and using Southern blot analysis (Fig. 3B).
To verify the functionality of the Blueﬂirt cassette, the B4 founder
was also crossed to ACTFlpe ‘‘deleter’’ mice expressing an
enhanced version of Flp recombinase (designated Flpe) from the
ubiquitous human b-actin promoter [18]. All the offspring with
the Rosa26-Blueﬂirt+/ACTFlpe+ genotype including embryos, pups,
and adult mice displayed whole-body expression of the ﬂuorescent
TagBFP protein, thus proving the function of the conditional con-
struct (Fig. 3C). Furthermore, we sequenced the Blueﬂirt allele
(including the ﬂanking chromosomal regions) using overlapping
fragments ampliﬁed from B4 mouse genomic DNA and conﬁrmed
correct targeting of the locus (not shown). Since the Rosa26-
Blueﬂirt F1 litter was born in lower than standard Mendelian ratio,
we also sequenced the second Rosa26 allele in all these mice. The
sequencing revealed that the animals harbor all four allelic Rosa26
variants (including the Blueﬂirt allele), indicating that the founder
animal is a genetic mosaic. However, extensive sequencing of the
TALEN target site in mice harboring TurboRFP construct did not
reveal any mosaicism, and one or two Rosa26 modiﬁed alleles
per animal were detected (Supplementary Fig. S1).
3.3. Assessment of TALENRosa26 off-targeting
To analyze the speciﬁcity of TALENRosa26, we constructed a
reporter plasmid pAR-TurboRFP and assayed TALENRosa26 nuclease
activity using the original Rosa26 sequence and several related rec-
ognition sites. The assay is based on reconstitution of the TurboRFP
gene open reading frame (ORF) through the single-strand anneal-
ing (SSA) repair mechanism (Fig. 4A; details are given in Section
2) [13,17,19]. The TALENRosa26-speciﬁc site and further three
genomic sequences with highest similarity to the TALENRosa26
target sequence (designated OTCh11, OTCh12, and OTCh16; Supple-
mentary Fig. S2) were cloned into pAR-TurboRFP and individually
co-transfected with the TALENRosa26-producing plasmid into
mouse NIH3T3 cells. The transfection efﬁciency was monitored
using EGFP ﬂuorescent protein produced from the pAR-TurboRFP
reporter. The cells were analyzed 72 h later using ﬂuorescent
microscopy (Fig. 4B) or ﬂow cytometry (Supplementary Fig. S3).
As expected, TurboRFP expression was observed only in cells trans-
fected with the construct harboring the Rosa26 target site and not
in cells transfected with the other pAR-TurboRFP constructs, thus
indicating speciﬁcity of TALENRosa26.
To examine the possible TALENRosa26 off-target activity in vivo,
OTCh11, OTCh12, and OTCh16 loci were analyzed in six founder mice.
Animals carrying bi- or multi-allelic mutations in the Rosa26 locus
(R6, R11, R15, B1, B4 and B14) were selected, assuming high activ-
ity of TALENs in these animals. The potential off-target sequences
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3986 P. Kasparek et al. / FEBS Letters 588 (2014) 3982–3988and the Rosa26 target site were ampliﬁed from genomic DNA using
PCR. The fragments were denatured and re-annealed with the cor-
responding PCR product ampliﬁed from DNA obtained fromwt ani-
mals and subjected to T7 endonuclease digestion (Fig. 4C). Since
this assay revealed that mutations were present in the Rosa26-
derived fragments only, we concluded that TALENRosa26 display
high selectivity for their target sequence under the described
conditions.
4. Discussion
Locus-speciﬁc integration of exogenous constructs mediated by
repair of DNA breaks introduced by programmable nucleases
might remarkably accelerate generation of genetically modiﬁed
animal models for biomedical research. In the present study, we
generated a TALENRosa26 pair to improve targeting into the mouseRosa26 locus. We showed that TALENRosa26 exhibit high speciﬁcity,
activity, and low cytotoxicity and may thus become the favored
tool for generation of transgenic animals. The test mouse strains
Rosa26-TurboRFP and Rosa26-Blueﬂirt were obtained at a fre-
quency of 2/17 and 1/17, respectively. Thus, the overall efﬁciency
of HR was 8.8%. Previous reports of Herman and colleagues [5]
and Meyer and colleagues [4] on ZFN-assisted Rosa26 targeting in
zygotes showed lower efﬁciency of 2% and 1.7–4.5%, respectively.
Thus, the obtained data document the superiority of TALENs. Nev-
ertheless, sequence analysis of the Rosa26 locus target site revealed
occurrence of genetic mosaicism in founder mice. The mosaicism
was subsequently conﬁrmed by sequencing of the Rosa26 locus
in F1 generation mice (not shown). This indicates nuclease activity
in later than the one-cell stage, as was recently described by Li and
colleagues, who observed simultaneous gene editing in zygotes
using TALENs [20]. This phenomenon could affect all nucleases
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Fig. 3. (A) Expression of TurboRFP in the R6 founder was manifested by red color of the skin. Photographs were taken at P2 (left image, the founder marked by arrow is placed
next to the non-transgenic sibling) or at P4 (middle image). Strong expression of TurboRFP in founder mice was conﬁrmed using ﬂuorescent microscopy on tail biopsies (right
image). (B) Southern blot analysis of F1 litter showed a single integration of TagBFP into the genome (lines 1, and 4–7). The radiolabelled probe covered the full-length
sequence of TagBFP and selectively hybridized with the 7025 bp BamHI restriction fragment (the 30 BamHI restriction site is present in the targeted allele only). No signal was
recorded in a Rosa26-Blueﬂirt- pup (line 2) or control genomic DNA isolated from wt C57Bl/6N mouse (line 3);Mw, molecular weight DNA marker. (C) Light ﬁeld (left image)
and ﬂuorescence microscopy images (middle image) of Rosa26-Blueﬂirt (left) and wt (right) embryos isolated at 13.5 p.c. Right panel shows combined light ﬁeld and
ﬂuorescent image of tail biopsies of ﬁve-week old Rosa26-Blueﬂirt (left) and wt (right).
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constitution of functional TurboRFP. EGFP is expressed from an independent human ferritin light chain composite promoter (hFerL) to monitor transfected cells; human
ferritin heavy chain composite promoter (hFerH) drives TurboRFP. (B) Reporter assay for TALENRosa26 activity. NIH 3T3 cells were transfected with the indicated reporter
constructs and TALENRosa26. TALEN activity manifested by expression of TurboRFP was detected only in cells co-transfected with reporter containing the Rosa26 target
sequence. (C) Screening for potential TALENRosa26 off-target activity in selected founder mice. PCR products harboring potential off-target site sequences (OTch11, OTch12,
OTch16) and the sequence of the Rosa26 target site (Rosa26) (upper panel) were hybridized with corresponding DNA fragments ampliﬁed from wt genomic DNA and digested
with T7 endonuclease (lower panel). TALEN activity manifested by cleavage of hybridized PCR products was detected only in PCR products containing Rosa26 target sequence.
P. Kasparek et al. / FEBS Letters 588 (2014) 3982–3988 3987used for gene targeting in zygotes. Thus, more attention and
appropriate genotyping including sequencing must be employed
to completely characterize transgenic animals generated using
programmable nucleases.
Another aspect that was examined was the topology of exoge-
nous DNA used as a template for HR. Tests in developing embryosrevealed that the linear fragment of Rosa26-Blueﬂirt construct
(lacking the vector backbone) integrated with higher efﬁciency in
comparison to the complete circular DNA constructs. In contrast,
previous studies did not show any differences in the integration
of circular or linearized constructs [4,5,21]. We suggest that higher
frequency of HR seen by a shorter linear template may be due to
3988 P. Kasparek et al. / FEBS Letters 588 (2014) 3982–3988the molar excess of the DNA fragment compared to the complete
construct when the same mass of construct is injected.
The possible off-target activity of TALENRosa26 was tested with a
T7 endonuclease assay and sequencing of the most similar sites.
Moreover, we devised and employed a transient TurboRFP gene
reconstitution assay to assess the TALENRosa26 speciﬁcity. None of
these analyses showed ‘‘off-targeting’’, indicating that usage of
these TALENRosa26 is more speciﬁc than previously described
Rosa26 modiﬁcation by the CRISPR/Cas9 system [22]. Moreover,
TALENRosa26 appeared to have more than twofold higher activity
than commercially available ZFNRosa26 and lower toxicity than
ZFNRosa26. These ﬁndings are in agreement with previous studies
comparing TALENs and ZFNs [23,24]. This phenomenon can be
explained by lower speciﬁcity of ZFNs DBD, since all mRNAs were
used at identical conditions and both genome-editing systems uti-
lize heterodimeric FokI nuclease [25,26].
In summary, our TALENRosa26 could be broadly used to circum-
vent gene targeting in ES cells and time-consuming backcrossing of
founder mice to yield a C57BL/6 background.
Acknowledgements
We express our special thanks to Inken Beck, Veronika Libova,
and Henrieta Palesova from the Transgenic and Archiving Module,
the Czech Centre for Phenogenomics (CCP), IMG Prague for their
excellent effort in generation of the transgenic models. This work
was supported by the Academy of Sciences of the Czech Republic
(RVO 68378050) and BIOCEV – Biotechnology and Biomedicine
Centre of the Academy of Sciences and Charles University
(CZ.1.05/1.1.00/02.0109), from the European Regional Develop-
ment Fund to V.K. and R.S., Grant Agency of the Czech Republic
Grant No. 14-33952S to V.K., and LM2011032 (MEYS) to R.S.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.febslet.2014.
09.014.
References
[1] Hsu, P.D., Lander, E.S. and Zhang, F. (2014) Development and applications of
CRISPR-Cas9 for genome engineering. Cell 157, 1262–1278.
[2] Dow, L.E. and Lowe, S.W. (2012) Life in the fast lane: mammalian disease
models in the genomics era. Cell 148, 1099–1109.
[3] Rouet, P., Smih, F. and Jasin, M. (1994) Expression of a site-speciﬁc
endonuclease stimulates homologous recombination in mammalian cells.
Proc. Natl. Acad. Sci. U.S.A. 91, 6064–6068.
[4] Meyer, M., de Angelis, M.H., Wurst, W. and Kuhn, R. (2010) Gene targeting by
homologous recombination in mouse zygotes mediated by zinc-ﬁnger
nucleases. Proc. Natl. Acad. Sci. U.S.A. 107, 15022–15026.
[5] Hermann, M., Maeder, M.L., Rector, K., Ruiz, J., Becher, B., Burki, K., Khayter, C.,
Aguzzi, A., Joung, J.K., Buch, T. and Pelczar, P. (2012) Evaluation of OPEN zinc
ﬁnger nucleases for direct gene targeting of the Rosa26 locus in mouse
embryos. PLoS ONE 7, e41796.
[6] Cathomen, T. and Joung, J.K. (2008) Zinc-ﬁnger nucleases: the next generation
emerges. Mol. Ther. 16, 1200–1207.
[7] Maeder, M.L., Thibodeau-Beganny, S., Osiak, A., Wright, D.A., Anthony, R.M.,
Eichtinger, M., Jiang, T., Foley, J.E., Winfrey, R.J., Townsend, J.A., Unger-Wallace,
E., Sander, J.D., Muller-Lerch, F., Fu, F., Pearlberg, J., Gobel, C., Dassie, J.P.,Pruett-Miller, T., Porteus, M.H., Sgroi, D.C., Iafrate, A.J., Dobbs, D., McCray Jr.,
P.B., Cathomen, T., Voytas, D.F. and Joung, J.K. (2008) Rapid ‘‘open-source’’
engineering of customized zinc-ﬁnger nucleases for highly efﬁcient gene
modiﬁcation. Mol. Cell. 31, 294–301.
[8] Sander, J.D., Dahlborg, E.J., Goodwin, M.J., Cade, L., Zhang, F., Cifuentes, D.,
Curtin, S.J., Blackburn, J.S., Thibodeau-Beganny, S., Qi, Y., Pierick, C.J., Hoffman,
E., Maeder, M.L., Khayter, C., Reyon, D., Dobbs, D., Langenau, D.M., Stupar, R.M.,
Giraldez, A.J., Voytas, D.F., Peterson, R.T., Yeh, J.R. and Joung, J.K. (2011)
Selection-free zinc-ﬁnger-nuclease engineering by context-dependent
assembly (CoDA). Nat. Meth. 8, 67–69.
[9] Moscou, M.J. and Bogdanove, A.J. (2009) A simple cipher governs DNA
recognition by TAL effectors. Science 326, 1501.
[10] Cermak, T., Doyle, E.L., Christian, M., Wang, L., Zhang, Y., Schmidt, C., Baller,
J.A., Somia, N.V., Bogdanove, A.J. and Voytas, D.F. (2011) Efﬁcient design and
assembly of custom TALEN and other TAL effector-based constructs for DNA
targeting. Nucleic Acids Res. 39, e82.
[11] Reyon, D., Tsai, S.Q., Khayter, C., Foden, J.A., Sander, J.D. and Joung, J.K. (2012)
FLASH assembly of TALENs for high-throughput genome editing. Nat.
Biotechnol. 30, 460–465.
[12] Panda, S.K., Wefers, B., Ortiz, O., Floss, T., Schmid, B., Haass, C., Wurst, W. and
Kuhn, R. (2013) Highly efﬁcient targeted mutagenesis in mice using TALENs.
Genetics 195, 703–713.
[13] Wefers, B., Meyer, M., Ortiz, O., Hrabe de Angelis, M., Hansen, J., Wurst, W. and
Kuhn, R. (2013) Direct production of mouse disease models by embryo
microinjection of TALENs and oligodeoxynucleotides. Proc. Natl. Acad. Sci.
U.S.A. 110, 3782–3787.
[14] Doyle, E.L., Booher, N.J., Standage, D.S., Voytas, D.F., Brendel, V.P., Vandyk, J.K.
and Bogdanove, A.J. (2012) TAL Effector-Nucleotide Targeter (TALE-NT) 2.0:
tools for TAL effector design and target prediction. Nucleic Acids Res. 40,
W117–W122.
[15] Flemr, M., Malik, R., Franke, V., Nejepinska, J., Sedlacek, R., Vlahovicek, K. and
Svoboda, P. (2013) A retrotransposon-driven dicer isoform directs endogenous
small interfering RNA production in mouse oocytes. Cell 155, 807–816.
[16] Soriano, P. (1999) Generalized lacZ expression with the Rosa26 Cre reporter
strain. Nat. Genet. 21, 70–71.
[17] Perez-Pinera, P., Ousterout, D.G., Brown, M.T. and Gersbach, C.A. (2012) Gene
targeting to the Rosa26 locus directed by engineered zinc ﬁnger nucleases.
Nucleic Acids Res. 40, 3741–3752.
[18] Rodriguez, C.I., Buchholz, F., Galloway, J., Sequerra, R., Kasper, J., Ayala, R.,
Stewart, A.F. and Dymecki, S.M. (2000) High-efﬁciency deleter mice show that
FLPe is an alternative to Cre-loxP. Nat. Genet. 25, 139–140.
[19] Bhakta, M.S. and Segal, D.J. (2010) The generation of zinc ﬁnger proteins by
modular assembly. Meth. Mol. Biol. 649, 3–30.
[20] Li, C., Qi, R., Singleterry, R., Hyle, J., Balch, A., Li, X., Sublett, J., Berns, H.,
Valentine, M., Valentine, V. and Sherr, C.J. (2014) Simultaneous gene editing by
injection of mRNAs encoding transcription activator-like effector nucleases
into mouse zygotes. Mol. Cell. Biol. 34, 1649–1658.
[21] Cui, X., Ji, D., Fisher, D.A., Wu, Y., Briner, D.M. and Weinstein, E.J. (2011)
Targeted integration in rat and mouse embryos with zinc-ﬁnger nucleases.
Nat. Biotechnol. 29, 64–67.
[22] Fujii, W., Kawasaki, K., Sugiura, K. and Naito, K. (2013) Efﬁcient generation of
large-scale genome-modiﬁed mice using gRNA and CAS9 endonuclease.
Nucleic Acids Res. 41, e187.
[23] Mussolino, C., Morbitzer, R., Lutge, F., Dannemann, N., Lahaye, T. and
Cathomen, T. (2011) A novel TALE nuclease scaffold enables high genome
editing activity in combination with low toxicity. Nucleic Acids Res. 39, 9283–
9293.
[24] Moore, F.E., Reyon, D., Sander, J.D., Martinez, S.A., Blackburn, J.S., Khayter, C.,
Ramirez, C.L., Joung, J.K. and Langenau, D.M. (2012) Improved somatic
mutagenesis in zebraﬁsh using transcription activator-like effector nucleases
(TALENs). PLoS ONE 7, e37877.
[25] Doyon, Y., Vo, T.D., Mendel, M.C., Greenberg, S.G., Wang, J., Xia, D.F., Miller, J.C.,
Urnov, F.D., Gregory, P.D. and Holmes, M.C. (2011) Enhancing zinc-ﬁnger-
nuclease activity with improved obligate heterodimeric architectures. Nat.
Meth. 8, 74–79.
[26] Cade, L., Reyon, D., Hwang, W.Y., Tsai, S.Q., Patel, S., Khayter, C., Joung, J.K.,
Sander, J.D., Peterson, R.T. and Yeh, J.R. (2012) Highly efﬁcient generation of
heritable zebraﬁsh gene mutations using homo- and heterodimeric TALENs.
Nucleic Acids Res. 40, 8001–8010.
[27] Casola, S. (2004) Conditional gene mutagenesis in B-lineage cells. Meth. Mol
Biol. 271, 91–109.
